Antibiotic based on crystalline monohydrate form of 1-carbocephalosporin
专利摘要:
The novel crystalline monohydrate of 7 beta -[2 min -(R)-2 min -phenyl-2 min -aminoacetamido]-3-chloro-3-(1-carbadethia-ce phem)-4-carboxylic acid is a valuable antibiotic and can be prepared from aqueous solutions by adjusting the pH to from 2 to 6. 公开号:SU1731058A3 申请号:SU884356543 申请日:1988-10-05 公开日:1992-04-30 发明作者:Элейн Пасини Кэрол 申请人:Эли Лилли Энд Компани (Фирма); IPC主号:
专利说明:
the penny was stirred for 20 minutes. DarcoW G60 carbon black (750 ml, about 250 g) was added to the solution and the resulting suspension was stirred at 24 18.5 cm Buchner funnel containing paper made of fiberglass and filter Hyf1o TO. Filtered solution about ° C 30 min. Suspension Filtered nitrile (500 ml) in 1 hour. The resulting suspension was filtered over glass fiber paper and the filter cake was washed with additional acetone. The substance on the filter cakes LY 163892, which can be used without additional purification). Water (1.62 L) and hydrochloric acid (12 molar, 43.0 MP) were combined and stirred at 20 ° C. 7j3- / 2 (R) 2 -phenyl 2 -amino-acetamido / -3 was added to the solution. -chloro 3- (1-carba, -1-children-acephaem) -4 carboxylic acid trihydra (200.0 g) and the resulting solution was stirred for 30 minutes. An additional amount of hydrochloric acid (10 ml) was added and the suspension was stirred for 20 minutes. to the solution, charcoal (8.0 g) was added to this solution and the resulting suspension was stirred for 30 minutes. The suspension was filtered through a Hyflo filter aid liner on glass fiber paper (the filter was then washed with 100 ml of water). The filtrate was heated to 45 ° C. 25 min. Triethylamine was slowly added to this filtrate to increase the pH of the solution to 1.8 (during the addition, the temperature of the filtrate was maintained in the range of 45-50 ° C). The solution was seeded with 100 mg of LY 163892 monohydrate, which resulted in suspension. The suspension was stirred for 1 hour pyr 50 ° C. “The addition of triethylamine slowly increased the pH of the suspension to 4.8, the Dann suspension was stirred for another 25 minutes at 50 ° C, then cooled to 25 ° C and stirred for 1 hour. The suspension was filtered through a 24 cm funnel. Buchner fitted with a polypropylene gasket. The filter cake was washed with water (2 ×, 250 ml), then the funnel was closed and the filter cake was under vacuum overnight. This filter cake was placed in a dryer with clean air at 30 ° C for 24 hours and obtained 119.90 g, yield 65.9%, of crystalline monohydrate LY 163892.
权利要求:
Claims (1) [1] Invention Formula eok having the following x-ray diffraction properties measured for a powder under irradiation with a wavelength of 9 1.541 And And on a copper tube with a nickel filter (Cu: Ni) with the following values of interplanar distances d and relative intensities 1/1 ) Relative intensity 1/1 5 Q 20 25 JQ 40
类似技术:
公开号 | 公开日 | 专利标题 SU1731058A3|1992-04-30|Antibiotic based on crystalline monohydrate form of 1-carbocephalosporin SU633483A3|1978-11-15|Method of obtaining cephalosporin derivatives as syn-isomer or mixture of syn- and anti-isomers or their salts SU867310A3|1981-09-23|Method of preparing 7-amino-3 |-|-3-cephem-4-carbohalic acid SU1487814A3|1989-06-15|Method of producing 7-amino-3-/3-|-1-propene-1-yl/-3-cephem-4-carboxylate SU1757468A3|1992-08-23|Method for preparation of crystalline 1-carbocephalosporine-2-water SU676166A3|1979-07-25|Method of obtaining cephalosporins or salts thereof SU1031409A3|1983-07-23|Process for preparing derivatives of 3-aminovinyl cephalosporin SU1356963A3|1987-11-30|Method of producing alfa-form crystal monohydrate of bis-hydrobromide of cephtasidime RU1804461C|1993-03-23|Method of crystalline cefadroxyl monohydrate synthesis RU2134265C1|1999-08-10|Bicyclic complexes beta-lactam/hydroxybenzoic acid, methods of beta-lactams synthesis HU176287B|1981-01-28|Process for producing 7-bracket-2-thienylacetamido-bracket closed-3-triasolylthiomethyl-3-cepheme-4-carboxylic acid derivative US5693790A|1997-12-02|Crystalline form of a cephalosporin antibiotic US4977257A|1990-12-11|DMF solvates of a β-lactam antibiotic AU614440B2|1991-08-29|Solvates of beta-lactam antibiotic GB2132616A|1984-07-11|Improvements in or relating to novel cephalosporin intermediates KR950011744B1|1995-10-09|Substantially anhydrous crystalline cefadroxil and method for producing it US5399686A|1995-03-21|Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate SU1277899A3|1986-12-15|Method for producing derivatives of pyrrolo|thiazole CA1200544A|1986-02-11|Crystalline cephalosporin SU784780A3|1980-11-30|Method of preparing d-isomers of penicillin derivatives or their pharmaceutically employed salts KR960015966B1|1996-11-25|Crystalline antibiotic intermediate SU559557A1|1979-01-05|Substituted imides of naphthostyryl-5,6-dicarboxylic acid as dye for synthetic fibres and method of obtaining them SU1193151A1|1985-11-23|Method of producing derivatives of 6,7-diaminoindoles KR830001970B1|1983-09-29|Method for preparing cephalosporin derivative SU980626A3|1982-12-07|Process for producing derivatives of cephalosporin or their alkali salts
同族专利:
公开号 | 公开日 FI884554A|1989-04-07| CN1029966C|1995-10-11| PL152022B1|1990-10-31| FI884554A0|1988-10-04| AT103916T|1994-04-15| IL87905D0|1989-03-31| HK15497A|1997-02-14| ES2063049T3|1995-01-01| YU46699B|1994-04-05| PL275093A1|1989-05-02| EG18529A|1993-04-30| CS666688A2|1989-11-14| AU598155B2|1990-06-14| DK553788D0|1988-10-04| DK553788A|1989-04-07| PT88662A|1988-11-01| PT88662B|1992-12-31| HU206348B|1992-10-28| ZA887409B|1990-06-27| DK170070B1|1995-05-15| KR970002637B1|1997-03-07| MY104063A|1993-11-30| HUT48884A|1989-07-28| MX13277A|1993-11-01| CS270594B2|1990-07-12| NZ226450A|1990-05-28| EP0311366A1|1989-04-12| JPH01128983A|1989-05-22| AR248407A1|1995-08-18| OA08958A|1990-11-30| NO884416L|1989-04-07| UA19149A|1997-12-25| KR890006644A|1989-06-15| DD273634A5|1989-11-22| AU2337288A|1989-04-06| BG47036A3|1990-04-16| IE883015L|1989-04-06| IE62108B1|1994-12-14| IL87905A|1992-06-21| PH31002A|1997-12-23| DE3888913D1|1994-05-11| NO884416D0|1988-10-05| YU184588A|1990-02-28| EP0311366B1|1994-04-06| JP2641745B2|1997-08-20| CN1032793A|1989-05-10| DE3888913T2|1994-08-11| CA1334970C|1995-03-28|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题 US3655656A|1970-06-04|1972-04-11|Lilly Co Eli|Crystalline cephalexin monohydrate| JPS6348520B2|1979-11-14|1988-09-29|Kyowa Hakko Kogyo Kk| ZA887408B|1987-10-07|1990-06-27|Lilly Co Eli|Monohydrate and solvates of a new beta-lactam antibiotic|ZA887408B|1987-10-07|1990-06-27|Lilly Co Eli|Monohydrate and solvates of a new beta-lactam antibiotic| CA2002597C|1988-11-14|1999-03-23|Thomas M. Eckrich|Solvates of b-lactam antibiotic| CA2002596A1|1988-11-14|1990-05-14|Thomas M. Eckrich|Hydrates of b-lactam antibiotic| CA2034592C|1990-01-26|2001-06-05|Ralph R. Pfeiffer|Crystalline hydrochloride of new beta-lactam antibiotic and process therefor| US5399686A|1993-06-04|1995-03-21|Eli Lilly And Company|Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate| US5374719A|1993-06-04|1994-12-20|Eli Lilly And Company|Process for converting loracarbef dihydrate to loracarbef monohydrate| US5352782A|1993-06-04|1994-10-04|Eli Lilly And Company|Process for preparing crystalline β-lactam monohydrate| US5550231A|1993-06-15|1996-08-27|Eli Lilly And Company|Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof| US5412094A|1993-06-28|1995-05-02|Eli Lilly And Company|Bicyclic beta-lactam/paraben complexes| US5580977A|1995-03-01|1996-12-03|Eli Lilly And Company|Process for preparing loracarbef monohydrate| US6001996A|1995-05-11|1999-12-14|Eli Lilly And Company|Complexes of cephalosporins and carbacephalosporins with parabens| US7056906B2|2001-09-21|2006-06-06|Schering Corporation|Combinations of hormone replacement therapy composition and sterol absorption inhibitor and treatments for vascular conditions in post-menopausal women| AT406364T|2003-03-07|2008-09-15|Schering Corp|SUBSTITUTED AZETIDINONE DERIVATIVES, THEIR PHARMACEUTICAL FORMULATIONS AND THEIR USE FOR THE TREATMENT OF HYPERCHOLESTEROLMIA| WO2004081003A1|2003-03-07|2004-09-23|Schering Corporation|Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholeterolemia|
法律状态:
优先权:
[返回顶部]
申请号 | 申请日 | 专利标题 US10576687A| true| 1987-10-06|1987-10-06| 相关专利
Sulfonates, polymers, resist compositions and patterning process
Washing machine
Washing machine
Device for fixture finishing and tension adjusting of membrane
Structure for Equipping Band in a Plane Cathode Ray Tube
Process for preparation of 7 alpha-carboxyl 9, 11-epoxy steroids and intermediates useful therein an
国家/地区
|